AAA- a further step towards a moratorium for aspirin in the primary prevention

Vasa. 2010 May;39(2):119-122. doi: 10.1024/0301-1526/a000016.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aged
  • Ankle Brachial Index
  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Atherosclerosis / complications
  • Atherosclerosis / diagnosis
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / mortality
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Evidence-Based Medicine
  • Female
  • Hemorrhage / chemically induced
  • Humans
  • Male
  • Middle Aged
  • Primary Prevention / methods*
  • Randomized Controlled Trials as Topic
  • Research Design
  • Risk Assessment
  • Scotland / epidemiology
  • Time Factors
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Aspirin